Opendata, web and dolomites

H2020 projects about "leukemia"

The page lists 72 projects related to the topic "leukemia".

# achronym  title  year 
1 ApoptoMDS Hematopoietic stem cell Apoptosis in bone marrow failure and MyeloDysplastic Syndromes: Friend or foe? 2015
2 NovLeuReg Identification and characterization of novel essential regulators of acute myeloid leukemia 2016
3 SENSITIVITYMARKERS Clinical validation of prognostic biomarkers of chemotherapy response in liquid biopsies 2015
4 Diricore Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy 2015
5 ONCOMECHAML Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia 2015
6 PNANOMED Personalized Nanomedicines for Leukemia Patients 2015
7 EpiTALL Dynamic interplay between DNA methylation, histone modifications and super enhancer activity in normal T cells and during malignant T cell transformation 2015
8 HemNichMDS Functional and Molecular Analyses of the Interplay between Hematopoietic and Mesenchymal Niche Cells in Human Myelodysplastic Syndromes. 2015
9 COMAL COMAL:COhesin Mutations in Acute Leukemia: from modeling and mechanisms to novel therapeutics 2015
10 UNEXPECTED Uncovering targets for ex vivo expansion of hematopoietic stem cells to enhance cell therapies of blood disorders 2015
11 IL7sigNETure IL-7/IL-7R signaling networks in health and malignancy 2015
12 M-Imm Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells 2015
13 LeukoPredict LeukoPredict: an in vitro system predicting and monitoring the therapeutic response of patients in the cure of Chronic Myeloid Leukemia (CML). 2016
14 INFANTLEUKEMIA GENOMIC, CELLULAR AND DEVELOPMENTAL RECONSTRUCTION OFINFANT MLL-AF4+ ACUTE LYMPHOBLASTIC LEUKEMIA 2016
15 MEDLEM Cost-effective microfluidic electronic devices for optimal drug administration based on fractional pharmacokinetics for leukemia treatments 2016
16 EVI1inCancer Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers 2016
17 CLLassify Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia 2016
18 SLIM Synthetic Lethal Interactions with nucleophosMin 1 2016
19 NVHSC Neurovascular interplay in the hematopoietic stem cell niches in homeostasis and myeloproliferative neoplasias 2016
20 EpigenomeProgramming An experimental and bioinformatic toolbox for functional epigenomics and its application to epigenetically making and breaking a cancer cell 2016
21 HEAL-BY-MIRNA microRNA replacement therapy for mature B cell neoplasias 2016
22 MARS Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach 2017
23 HOXA9 degradome Deciphering the machinery involved in stability of the transcription factor HOXA9. 2016
24 Oncosmart ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics 2016
25 SCUBA CANCERS Finding the genetic causes of contagious metastases under the sea 2017
26 MAMLE Understanding the mechanisms of human acute myeloid leukaemia (AML) evolution 2017
27 LEUKEMIC-TEs Unveiling the signature of transposable elements-derived transcripts – the transposcriptome – as a biomarker in human acute myeloid leukemia 2017
28 EwiSarc A novel in vivo platform to study and target undruggable Ewing onco-chimera. 2017
29 CATRATS Catalytic Enantioselective Allene Cycloisomerisation Reactions for Alkaloid Total Synthesis 2017
30 HARMONY Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 2017
31 METCLL Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy 2018
32 THAT IS HUNT Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors 2018
33 ContraNPM1AML Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia 2017
34 iAML-lncTARGET Targeting the transcriptional landscape in infant AML 2017
35 TREAT-NPM1-AML Improving therapy of NPM1-mutated AML 2017
36 bloodANDbone Blood and bone – conjoined twins in health and disease: bone marrow analogs for hematological and musculoskeletal diseases 2018
37 AltCheM In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia 2018
38 CanBioSe Novel 1D photonic metal oxide nanostructures for early stage cancer detection 2018
39 CLLCLONE Harnessing clonal evolution in chronic lymphocytic leukemia 2018
40 TET2rec Mechanisms of TET2 DNA demethylase recruitment to specific genomic regions 2018
41 CHROMABOLISM Chromatin-localized central metabolism regulating gene expression and cell identity 2018
42 Target5LO Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia 2018
43 HifLICs Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse 2019
44 REPTOL Pre-leukemic B cell repertoire alterations in patients with familial chronic lymphocytic leukemia: looking for evidence of a genetically-inherited defect in tolerance induction 2019
45 InTheMLLrBALL Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia 2018
46 IGpath Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas 2018
47 CARAMBA SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease 2018
48 LapIt Making AML treatment a clinical reality: A novel anti-IL7 receptor antibody to deliver Lap to 5LO positive cells 2019
49 ONCOSMART ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics 2018
50 KlotoDx KlotoDx A quick and cost-effective near-patient tool to identify sepsis-related bacteria and antibiotic resistances 2018
51 BloodVariome Genetic variation exposes regulators of blood cell formation in vivo in humans 2018
52 LeukemiaEnviron SIGNALING PROPENSITY IN THE MICROENVIRONMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA 2019
53 TALE Therapeutic Allele Engineering: A novel technology for cell therapy 2019
54 scTALLmap Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia 2019
55 SyLeNCe Synapses between Leukaemia and its Neighbouring Cells 2020
56 BCLLatlas Single-cell genomics to comprehensively understand healthy B-cell maturation and transformation to chronic lymphocytic leukemia 2019
57 Exh-Res-CART Exhaustion-resistant CAR-T cells for the treatment of solid tumours 2019
58 PhotoStem Photoswitching molecules for the spatiotemporal control of cancer stem cells with light 2019
59 IDEAL Inhibitor of DUX4-IGH to Erase Acute lymphoblastic Leukaemia 2020
60 PMLingAML Using PML nuclear body biology to identify potential AML treatment targets 2020
61 CB-103 First effective targeted therapy for T-cell acute lymphoblastic leukemia (T-ALL) and other NOTCH pathway driven cancers 2019
62 Mitobetes The role of Von Willebrand Domain-containing Protein 8 in mitochondrial physiology 2020
63 ARCH AGE-RELATED CHANGES IN HEMATOPOIESIS 2019
64 IL7RsignaTHER Antibody-based IL-7R targeted therapies 2020
65 SLAM-Dx Diagnostic drug response-profiling using SLAMseq 2019
66 M6AQuantKit Development and commercialization of kit for quantitative interrogation of a key RNA modification 2020
67 PreventALL Prevention of childhood Acute Lymphoblastic Leukemia immunology links oncology 2020
68 RECOBIN-PROTACs Reversible Covalently Binding PROTACs Technology for Protein Degradation in Cancer Therapy 2020
69 LINKER Elucidating transcriptional rewiring on hematological malignancies via computational methods 2020
70 Hemstem Targeting leukaemia by modulating hematopoietic stem cell competitiveness 2020
71 ChRONAM-H Chromatin Regulation Of Normal And Malignant Haematopoiesis 2020
72 Catenin-Condensation The effect of β-catenin condensation on the Wnt-pathway 2020